Page last updated: 2024-11-12

ag 2000

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

AG 2000: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14234897
SCHEMBL ID9814798
MeSH IDM0163564

Synonyms (7)

Synonym
ag 2000
111712-16-4
ag-2000
5h-pyrido(1',2':4,5)(1,2,4)thiadiazino(2,3-a)benzimidazol-13-ium, 4-methyl-3-(2,2,2-trifluoroethoxy)-, tetrafluoroborate(1-)
SCHEMBL9814798
6-methyl-5-(2,2,2-trifluoroethoxy)-9-thia-10,17-diaza-2-azoniatetracyclo[8.7.0.02,7.011,16]heptadeca-1(17),2(7),3,5,11,13,15-heptaene;tetrafluoroborate
ixvzbeywfwrnja-uhfffaoysa-n

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Relative resistance was not significantly changed by co-incubation with a non-cytotoxic dosage of these inhibitors."( Role of sodium pump systems to determine sensitivity to mitomycin C in non-small cell lung cancer cell lines.
Bando, T; Fujimura, M; Kasahara, K; Matsuda, T; Nakatsumi, Y; Numata, Y; Shibata, K,
)
0.13
" Relative resistance was not altered by co-incubation with a non-cytotoxic dosage of AG-2000."( Effect of proton pump inhibitor on cell growth and sensitivity to cis-diamminedichloroplatinum(II) in non-small cell lung cancer cell lines.
Bando, T; Fujimura, M; Kasahara, K; Matsuda, T; Nakatsumi, Y; Shibata, K,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.38 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index51.37 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (27.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]